Therapeutics

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the …

Precision medicine specialist Relay Therapeutics (NASDAQ: RLAY) probably didn’t want this holiday-shortened trading week to end, since it was quite the stock market star during the period. According …

TG Therapeutics Inc. (NASDAQ:TGTX) shares advanced Wednesday after the biopharmaceutical company announced the completion of a $100 million share repurchase program and unveiled plans for an additional $100 …

Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the best strong buy growth stocks to buy now. On August 27, H.C. Wainwright raised the firm’s price target on Summit Therapeutics …

Neumora Therapeutics Inc. (NASDAQ:NMRA) is one of the best IPO stocks to buy according to Wall Street analysts. Earlier on July 9, Neumora Therapeutics initiated a Phase 1 …

PTC Therapeutics (PTCT) on Tuesday announced that they received a complete response letter for vatiquinone in Friedreich’s ataxia, with the FDA stating that substantial evidence of efficacy was …

Key Takeaways Viking Therapeutics reported a large number of patients dropped out of a study of its experimental weight-loss pill. Overall, 28% of those taking VK2735 left the …

Design Therapeutics, Inc. (NASDAQ:DSGN – Free Report) – Equities research analysts at Leerink Partnrs reduced their Q3 2025 earnings estimates for shares of Design Therapeutics in a research …

Cash, cash equivalents and marketable securities at June 30, 2025, totalled $454.3 million, as compared to $588.0 million at December 31, 2024. The decrease was primarily driven by …

Biotech Nektar Therapeutics (NASDAQ: NKTR) unveiled its latest quarterly earnings after the stock market’s close on Thursday, and the investor reaction was strong the following day. Happily for …